Literature DB >> 1097517

Inhibition of in vitro lymphokine synthesis by glucocorticosteroids.

S M Wahl, L C Altman, D L Rosenstreich.   

Abstract

At pharmacological levels, glucocorticosteroids inhibited two antigen-induced lymphocyte functions, in vitro proliferation and lymphokine synthesis. Lymphocyte production of both macrophage chemotactic factor (CTX) and macrophage inhibition factor (MIF) were decreased in the presence of hydrocortisone. The corticosteroid also blocked the action of MIF on macrophages but did not interfere with the action of CTX on macrophages. Thus, steroids can suppress the immune response at two different stages: by blocking lymphocyte activation and mediator synthesis and also by interfering with the interaction of certain effector molecules with their target cells. Furthermore, these findings suggested that MIF and CTX have distinct mechanisms of action on the effector macrophages, one being sensitive and one resistant to steroids.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1097517

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Glucocorticoids administered in vivo inhibit human suppressor T lymphocyte function and diminish B lymphocyte responsiveness in in vitro immunoglobulin synthesis.

Authors:  A Saxon; R H Stevens; S J Ramer; P J Clements; D T Yu
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

2.  Antigenic competition between horse and sheep red blood cells as a hormone-dependent phenomenon.

Authors:  H O Besedovsky; A Del Rey; E Sorkin
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

Review 3.  The antinflammatory effects of glucocorticosteroids. A brief review of the literature.

Authors:  A M Dannenberg
Journal:  Inflammation       Date:  1979-07       Impact factor: 4.092

Review 4.  Corticosteroids in liver disease: possible mechanisms of action, pharmacology, and rational use.

Authors:  A R Tanner; L W Powell
Journal:  Gut       Date:  1979-12       Impact factor: 23.059

5.  Network of immune-neuroendocrine interactions.

Authors:  H Besedovsky; E Sorkin
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

Review 6.  An overview of glucocorticoid anti-inflammatory actions.

Authors:  R P Schleimer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Production of the lymphokine, macrophage aggregating factor, is not inhibited by histamine.

Authors:  P Badenoch-Jones
Journal:  Experientia       Date:  1982-10-15

8.  Dexamethasone exacerbates cytotoxic chemotherapy induced lethargy and weight loss in female tumor free mice.

Authors:  John Wong; Lisa T Tran; Kaari A Lynch; Lisa J Wood
Journal:  Cancer Biol Ther       Date:  2017-12-12       Impact factor: 4.742

9.  Inhibition of the accumulation of macrophages and the generation of macrophage chemotactic activity by dexamethasone in concanavalin A-induced peritonitis of mice.

Authors:  I Nagaoka; H Kaneko; T Yamashita
Journal:  Agents Actions       Date:  1988-08

10.  Dexamethasone suppresses concanavalin A-induced production of chemotactic lymphokines by releasing a soluble factor from splenic T lymphocytes.

Authors:  M Hirashima; K Sakata; K Tashiro; T Yoshimura; H Hayashi
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.